01 1Zhejiang Huahai Pharmaceutical
01 1OSELTAMIVIR PHOSPHATE USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-02-09
Pay. Date : 2023-12-29
DMF Number : 39314
Submission : 2023-12-20
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OSELTAMIVIR PHOSPHATE USP, with a corresponding US DMF Number 39314.
Remarkably, this DMF maintains an Active status since its submission on December 20, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 09, 2024, and payment made on December 29, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
